Emera Incorporated
Emera Incorporated Fundamental Analysis
Emera Incorporated (EMRAF) shows weak financial fundamentals with a PE ratio of 19.40, profit margin of 11.54%, and ROE of 7.23%. The company generates $8.2B in annual revenue with weak year-over-year growth of -4.80%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 12.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze EMRAF's fundamental strength across five key dimensions:
Efficiency Score
WeakEMRAF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentEMRAF trades at attractive valuation levels.
Growth Score
WeakEMRAF faces weak or negative growth trends.
Financial Health Score
WeakEMRAF carries high financial risk with limited liquidity.
Profitability Score
WeakEMRAF struggles to sustain strong margins.
Key Financial Metrics
Is EMRAF Expensive or Cheap?
P/E Ratio
EMRAF trades at 19.40 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, EMRAF's PEG of 0.14 indicates potential undervaluation.
Price to Book
The market values Emera Incorporated at 1.40 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.50 times EBITDA. This is generally considered low.
How Well Does EMRAF Make Money?
Net Profit Margin
For every $100 in sales, Emera Incorporated keeps $11.54 as profit after all expenses.
Operating Margin
Core operations generate 20.35 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.23 in profit for every $100 of shareholder equity.
ROA
Emera Incorporated generates $2.23 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Emera Incorporated generates strong operating cash flow of $2.25B, reflecting robust business health.
Free Cash Flow
Emera Incorporated generates weak or negative free cash flow of $-1.27B, restricting financial flexibility.
FCF Per Share
Each share generates $-4.26 in free cash annually.
FCF Yield
EMRAF converts -6.91% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
19.40
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.14
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.40
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.23
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.53
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.68
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.07
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How EMRAF Stacks Against Its Sector Peers
| Metric | EMRAF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 19.40 | 19.51 | Neutral |
| ROE | 7.23% | 940.00% | Weak |
| Net Margin | 11.54% | 9081.00% | Weak |
| Debt/Equity | 1.53 | 1.73 | Neutral |
| Current Ratio | 0.68 | 1.48 | Weak Liquidity |
| ROA | 2.23% | -169.00% (disorted) | Weak |
EMRAF outperforms its industry in 0 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Emera Incorporated's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-2.20%
Industry Style: Defensive, Dividend, Income
DecliningEPS CAGR
-33.52%
Industry Style: Defensive, Dividend, Income
DecliningFCF CAGR
44.03%
Industry Style: Defensive, Dividend, Income
High Growth